Differential pricing of drugs: a role for cost-effectiveness analysis?
- 1 June 2002
- journal article
- Published by Elsevier in The Lancet
- Vol. 359 (9323) , 2105-2107
- https://doi.org/10.1016/s0140-6736(02)08911-0
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- HIV/AIDS Treatment for MillionsScience, 2001
- Can economic evaluation guidelines improve efficiency in resource allocation? The cases of Portugal, The Netherlands, Finland, and the United Kingdom.International Journal of Technology Assessment in Health Care, 2000
- Access to Essential Drugs in Poor CountriesA Lost Battle?JAMA, 1999
- Use of economic evaluation guidelines: 2 years’ experience in CanadaHealth Economics, 1998
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Basing Prescription Drug Payment on Economic Analysis: The Case of AustraliaHealth Affairs, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991